![]() |
Most Neurologists Plan to Prescribe Oral Multiple Sclerosis Drugs, but Will Proceed w
Sep 1, 2010 - In a study published this week by Majestic Research , almost 60% of neurologists expressed unaided concern about the side effects/safety of oral MS therapies in development, including NVS's Gilenia and MRK/EMD Serono's oral cladribine.
More... (From Topix Neurology) |
All times are GMT -5. The time now is 10:10 PM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.